Impact of investigational microbiota therapeutic RBX2660 on the gut microbiome and resistome revealed by a placebo-controlled clinical trial

BACKGROUND: Intestinal microbiota restoration can be achieved by complementing a subject’s perturbed microbiota with that of a healthy donor. Recurrent Clostridioides difficile infection (rCDI) is one key application of such treatment. Another emerging application of interest is reducing antibiotic-...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Microbiome
Auteurs principaux: Kwak, Suryang, Choi, JooHee, Hink, Tiffany, Reske, Kimberly A., Blount, Kenneth, Jones, Courtney, Bost, Margaret H., Sun, Xiaoqing, Burnham, Carey-Ann D., Dubberke, Erik R., Dantas, Gautam
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2020
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7457799/
https://ncbi.nlm.nih.gov/pubmed/32862830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40168-020-00907-9
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires